You can find more information about M17 leucyl aminopeptidase using the following links:

PlasmoDB - the Plasmodium genome resource
The TDR Targets Database

Subcellular Localization

PDB protein strucure

Affecting Drugs
Drug Name PubMed Articles (year of publication)
((4-(1H-Pyrazol-1-yl)phenyl)(amino)methyl)phosphonic acid
2-(4-bromophenyl)-2-(butoxymethylamino)ethanehydroxamic acid
2-(4-chlorophenyl)-5-fluoro-1,2-benzothiazol-3-one
2-(butoxymethylamino)-2-[4-(2,4,6-trifluorocyclohexa-2,4-dien-1-yl)phenyl]ethanehydroxamic acid
2-[[(1-Amino-4-phenylbutyl)hydroxyphosphinyl]-methyl]-3-(4-hydroxyphenyl)propionic Acid
2-[[(1-Amino-4-phenylbutyl)hydroxyphosphinyl]-methyl]-3-phenylpropionic Acid
2-amino-1-hydroxyphosphonates
7-amino-4-phenyl-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one
Alln
Alpha-aminoalkylphosphonates
and N-(1-(4-(1H-pyrazol-1-yl)phenyl)-2-(hydroxyamino)-2-oxoethyl)pivalamide
Bestatin
Bestatin
Bufexamac
CHEMBL369831
CHEMBL426945
Chr-2863
Chr-6768
E-64
Hphep[ch2]phe) and 5 (hphep[ch2]tyr
Menadione
MMV020750
Mmv665805
N-(2-(Hydroxyamino)–1-(4'-(hydroxymethyl)-[1,1'-biphenyl]–4-yl)–2-oxoethyl)pivalamide
N-(2-(Hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro-[1,1'-biphenyl]-4-yl)ethyl)adamantane1-carboxamide
N-(2-(hydroxyamino)-2-oxo-1-(4-(3,4,5-trifluorocyclohexyl)phenyl)ethyl)-3-methylbutanamide
Nitrobestatin
Pepstatin
Pro-arg-fluoromethyl ketone
silver nanoparticles
Substrate specificty suggested target
Suggested target
tert-butyl (1-(4-(1H-pyrazol-1-yl)phenyl)-2-(hydroxyamino)-2-oxoethyl)carbamate
tert-butyl N-[1-(4-bromophenyl)-2-(hydroxyamino)-2-oxo-ethyl]carbamate
Tosedostat